91丝瓜视频

Christina Greenaway

Chris Greenaway MD, FRCPC, MSc听

Associate Professor, Department of Medicine, 91丝瓜视频

Staff Physician Department of Internal Medicine, Department of Diagnostic Medicine, and Division of Infectious Diseases, SMBD-Jewish General Hospital

Staff Physician J.D. MacLean Center for Tropical Diseases at 91丝瓜视频, 91丝瓜视频 Hospital Center

Associate Member, Department of Epidemiology, Biostatistics and Occupational Health, 91丝瓜视频

Principle Investigator, Centre for Clinical Epidemiology of the Lady Davis Institute for Medical Research

Jewish General Hospital

Division of Infectious Disease
3755 C么te St. Catherine Road
Room E-0057
Montreal, QC, Canada H3T 1E2

Tel:听514-340-8222 #22933

Email:ca.greenaway@mcgill.ca

Research


Chris Greenaway is an infectious disease physician, clinician researcher and internationally recognized expert in migrant health. Her research program has focused on identifying and addressing the infectious disease health disparities among migrants. The overall objective of her research program is to promote the health of the migrant population and decrease their health disparities. To achieve this she has conducted observational studies, retrospective cohort studies with large linked administrative datasets, systematic reviews, economic analyses and has developed screening and clinical guidelines for migrants in Canada and Europe using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology.

Chris has a long standing interest in TB and been involved in clinical care of patients with TB for almost 20 years. She established the TB clinic at the Jewish General Hospital in 2001. She has conducted research related to the diagnosis and treatment of TB and the TB burden and screening strategies for the migrant population. She has written screening guidelines for active and latent TB for the Canadian Collaboration for Immigrant and Refugee Health (CMAJ 2011) and for the European Centers for Disease Control (2018 ). She is a co-PI on a multi-province CIHR funded study (2017-2020) that is using linked administrative databases to develop a risk prediction tool for the development of active TB among migrants. This data will be used to determine the most cost-effective screening and treatment strategy to achieve TB elimination in Canada.